Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 71.79B | 72.34B | 72.60B | 69.54B | 59.34B | 56.54B |
Gross Profit | 16.63B | 17.21B | 16.59B | 15.93B | 14.48B | 14.36B |
EBITDA | 6.91B | 6.94B | 7.33B | 6.73B | 5.70B | 5.83B |
Net Income | 3.81B | 3.55B | 4.24B | 3.96B | 3.71B | 3.54B |
Balance Sheet | ||||||
Total Assets | 63.19B | 62.95B | 64.24B | 60.94B | 55.87B | 52.38B |
Cash, Cash Equivalents and Short-Term Investments | 1.05B | 1.20B | 1.56B | 1.10B | 1.73B | 1.32B |
Total Debt | 400.00M | 420.00M | 400.00M | 500.00M | 503.00M | 503.00M |
Total Liabilities | 13.66B | 13.52B | 14.57B | 15.39B | 14.12B | 12.73B |
Stockholders Equity | 49.46B | 49.35B | 49.62B | 45.50B | 41.70B | 39.61B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.39B | 3.21B | -377.00M | 508.00M | 2.63B |
Operating Cash Flow | 0.00 | 5.05B | 6.50B | 2.24B | 2.17B | 3.67B |
Investing Cash Flow | 0.00 | -2.19B | -2.98B | -2.82B | -1.56B | -207.00M |
Financing Cash Flow | 0.00 | -2.28B | -1.69B | -1.49B | -1.44B | -1.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥56.69B | 12.79 | 4.45% | 4.63% | 27.74% | ||
72 Outperform | ¥59.67B | 27.06 | 0.52% | 13.62% | 24.54% | ||
70 Outperform | ¥95.28B | 8.25 | 4.08% | -3.45% | -3.91% | ||
68 Neutral | ¥65.29B | 18.39 | 3.91% | -0.35% | -16.23% | ||
65 Neutral | $27.33B | 15.36 | -4.01% | 3.14% | 1.00% | 1.98% | |
64 Neutral | ¥82.83B | 31.09 | 3.44% | 4.60% | -70.62% | ||
56 Neutral | ¥51.54B | 13.04 | 2.74% | 1.11% | ― |